Platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists derived from amidinoindoles

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 1, 1996, Pages 81-86

  Sall, Daniel J ^a   Arfsten, Ann E ^b   Berry, Dennis R ^a   Denney, Michael L ^a   Harms, Cathy S ^a   McCowan, Jefferson R ^a   Ray, Judith K ^a   Scarborough, Robert M ^b   Um, Suzane L ^a   Utterback, Barbara G ^a   Jakubowski, Joseph A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; INDOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHOBICITY; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION;

EID: 0030028134     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(95)00563-9     Document Type: Article

References (34)

1. (a) Fuster, V.; Steele, P. M.; Chesebro, J. H. J. Am. Coll. Cardiol. 1985, 5, 175B.
2. (b) Smitherman, T. C.; Milam, M.; Woo, J.; Willerson, J. T.; Frenkel, E. P. Am. J. Cardiol. 1981, 48, 395.
3. (c) Hamm, C. W.; Lorenz, R. L.; Bleifeld, W.; Kupper. W.; Wober, W.; Weber, P. C. J. Am. Coll. Cardiol. 1987, 10, 998.
4. (d) Fitzgerald, D. J.; Roy, L.; Catella, F.; Fitzgerald, G. A. N. Engl. J. Med. 1986, 315, 983.
5. (a) Bennett, J. S.; Vilaire, G. J. Clin. Invest. 1979, 64, 1393.
6. (b) Peerschke, E. I.; Zucker, M. B.; Grant, R. A.; Egan, J. J.; Johnson, M. M. Blood 1980, 55, 841.
7. (c) Hawiger, J; Parkinson, S.; Timmons, S. Nature, 1980, 283, 195.
8. (a) Phillips, D. R.; Charo, I. F.; Parise, L. V.; Fitzgerald, L. A. Blood 1988, 71, 831.
9. (b) Andrieux, A.; Hudry-Clergeon, G.; Ryckewaert, J.-J.; Chapel. A.; Ginsberg, M. H.; Plow, E. F.; Marguerie, G. J. Biol. Chem. 1989, 264, 9258.
10. (c) Hawiger, J.; Kloczewiak, M.; Bednarek, M. A.; Timmons, S. Biochemistry 1989, 28, 2909.
11. (a) Nichols, A. J.; Ruffolo Jr., R. R.; Huffman, W. F.; Poste, G.; Samanen, J. Trends Pharm. Sci. 1992, 13, 413.
12. (b) Blackburn, B. K.; Gadek, T. R. Ann. Rev. Med. Chem. 1993, 28, 79.
13. (a) Zablocki, J. A.; Miyano, M.; Garland, R. B.; Pireh, D.; Schretzman, L.; Rao, S. N.; Lindmark, R. J.; Panzer-Knodle, S. G.; Nicholson, N. S.; Taite, B. B.; Salyers, A. K.; King, L. W.; Campion, J. G.; Feigen, L. P. J. Med. Chem. 1993, 36, 1811.
14. (b) McDowell, R. S.; Blackburn, B. K.; Gadek, T. R.; McGee, L. R.; Rawson, T.; Reynolds, M. E.; Robarge, K. D.; Somers, T. C.; Thorsett E. D.; Tischler, M.; Webb II, R. R.; Venuti, M. C. J. Am. Chem. Soc. 1994, 116, 5077.
15. (c) Alig, L.; Edenhofer, A.; Hadvary, P.; Hurzeler, M.; Knopp, D.; Muller, M.; Steiner, B.; Trzeciak, A.; Weller, T. J. Med. Chem. 1992, 35, 4393.
16. (d) Ku, T. W.; Miller, W. H.; Bondinell, W. E.; Erhard, K. F.; Keenan, R. M.; Nichols, A. J.; Peishoff, C. E.; Samanen, J. M.; Wong, A. S.; Huffman, W. F. J. Med. Chem. 1995, 38, 9.
17. Alig, L.; Edenhofer, A.; Hadvary, P.; Hurzeler, M.; Knopp, D.; Muller, M.; Steiner, B.; Trzeciak, A.; Weller, T. J. Med. Chem. 1992, 35, 4393.
18. Geratz, J. D.; Stevens, F. M.; Polakoski, K. L.; Parrish, R. F.; Tidwell, R. R. Arch. Biochem. Biophys. 1979, 197, 551.
19. 50 values represent the avenge of four separate determinations (n = 4).
20. 50 values represent the average of three separate determinations for active compounds (n = 3) and two (n = 2) for inactive agents (> 100 μM).
21. Interatomic distances were measured using Macromodel (version 4.0) on an Antares Silicon Graphics Workstation R4400 using unsubstituted indole which had been minimized with the MM3 force field.
22. 2. Scarborough R. M.; Naugbtoa, M. A.; Teng W.; Rose, J. W.; Phillips, D. R.; Nannizzi, L.; Arfsten, A.; Campbell, A. M.; Charo, I. F. J. Biol. Chem. 1993, 268, 1066.
23. Egbertson, M. S.; Naylor, A. M.; Hartman, G. D.; Cook, J. J.; Gould, R. J.; Holahan, M. A.; Lynch Jr., J. J.; Stranieri, M. T.; Vassallo, L. M. Bio. Med. Chem. Lett. 1994, 4, 1835.
24. Calculated log P values (clog P) were determined on a Silicon Graphics R4400 Workstation using PCmodels (version 4.41) from Daylight Chemical Information Systems, Inc., Irvine, CA.
25. vβ3 (VNR), biotinylated vitronectin, alkaline phosphatase-labeled goat antibiotin and p-nitro phenol phosphate as described by Scarborough, R. M.; Rose, J. W.; Naughton, M. A.; Phillips D. R.; Nannizzi, L.; Arfsten, A.; Campbell, A. M.; Charo, I. F. J. Biol Chem. 1993, 268, 1058. Measurements were performed in quadruplicate, and standard deviations were less than 10 % of the mean.
26. Lindwall, H. G.; Mantell, G. J. J. Org. Chem. 1953, 18, 345.
27. Reissert, A.; Heller, H. Ber. 1904, 37, 4364.
28. (a) Ashley, J. N.; Barber, H. J.; Ewins, A. J.; Newbery, G.; Self, A. D. H. J. Chem. Soc. 1942, 103.
29. (b) Berg, S. S.; Newbery, G. J. Chem. Soc. 1949, 642.
30. 1H NMR, MS, IR and the experimentally determined elemental percentages of C, H and N were within 0.4 % of theoretical values.
31. Kermack, W. O. J. Chem. Soc. 1924, 125, 2285.
32. Wagner, G.; Voigt, B.; Vieweg, H. Pharmazie 1984, 39, 226.
33. Batcho A. D.; Leimgruber, W.; US Patent 3, 976, 639, 1976.
34. Bal, B. S.; Childers Jr., W. E.; Pinnick, H. W. Tetrahedron 1981, 37, 2091.